Leading innovative biologic and smallmolecule therapeutic development in Russia
BIOCAD, the leading Russian biotechnology company, owns a robust portfolio of globally marketed products and is focusing its efforts on research and development of novel compounds and biologics, primarily for oncology. Building on its national leadership position, the company is seeking to expand its international presence through joint clinical development partnerships.
No comments yet.